TDM of theophylline--compliance evaluation. 1988

M J Otero, and A Martin, and M Barrueco, and M J Garcia, and A Dominguez-Gil
Pharmacy Service, Hospital INSALUD V. de la Vega, Salamanca, Spain.

Non-compliance to dosage regimes is an important clinical problem with severe repercussions for the management of chronic illnesses requiring continued treatment. In the present study, we evaluated the degree of non-compliance in a group of 100 patients with chronic asthma undergoing continued treatment with theophylline, and the effect of the application of a monitoring programme on their degree of compliance. The evaluation was carried out by anamnesis and from the level/dose ratio. In the control group studied (n = 50) the degree of non-compliance was 44% and in the previously monitored group (n = 50) it was 18%. Serum theophylline levels in the former were: 7.6 +/- 5.8 micrograms/ml, significantly lower (P less than 0.005) than that observed in the latter: 10.1 +/- 4.0 micrograms/ml. The use of monitoring programmes can improve the degree of compliance.

UI MeSH Term Description Entries
D008173 Lung Diseases, Obstructive Any disorder marked by obstruction of conducting airways of the lung. AIRWAY OBSTRUCTION may be acute, chronic, intermittent, or persistent. Obstructive Lung Diseases,Obstructive Pulmonary Diseases,Lung Disease, Obstructive,Obstructive Lung Disease,Obstructive Pulmonary Disease,Pulmonary Disease, Obstructive,Pulmonary Diseases, Obstructive
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010349 Patient Compliance Voluntary cooperation of the patient in following a prescribed regimen. Client Adherence,Client Compliance,Non-Adherent Patient,Patient Adherence,Patient Cooperation,Patient Noncompliance,Patient Non-Adherence,Patient Non-Compliance,Patient Nonadherence,Therapeutic Compliance,Treatment Compliance,Adherence, Client,Adherence, Patient,Client Compliances,Compliance, Client,Compliance, Patient,Compliance, Therapeutic,Compliance, Treatment,Cooperation, Patient,Non Adherent Patient,Non-Adherence, Patient,Non-Adherent Patients,Non-Compliance, Patient,Nonadherence, Patient,Noncompliance, Patient,Patient Non Adherence,Patient Non Compliance,Patient, Non-Adherent,Therapeutic Compliances,Treatment Compliances
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D013806 Theophylline A methyl xanthine derivative from tea with diuretic, smooth muscle relaxant, bronchial dilation, cardiac and central nervous system stimulant activities. Theophylline inhibits the 3',5'-CYCLIC NUCLEOTIDE PHOSPHODIESTERASE that degrades CYCLIC AMP thus potentiates the actions of agents that act through ADENYLYL CYCLASES and cyclic AMP. 1,3-Dimethylxanthine,3,7-Dihydro-1,3-dimethyl-1H-purine-2,6-dione,Accurbron,Aerobin,Aerolate,Afonilum Retard,Aquaphyllin,Armophylline,Bronchoparat,Bronkodyl,Constant-T,Elixophyllin,Euphylong,Glycine Theophyllinate,Lodrane,Monospan,Nuelin,Nuelin S.A.,Quibron T-SR,Slo-Phyllin,Somophyllin-T,Sustaire,Synophylate,Theo Von Ct,Theo-24,Theo-Dur,Theobid,Theocin,Theoconfin Continuous,Theodur,Theolair,Theolix,Theon,Theonite,Theopek,Theophylline Anhydrous,Theophylline Sodium Glycinate,Theospan,Theostat,Theovent,Uniphyl,Uniphyllin,Uniphylline,1,3 Dimethylxanthine,Anhydrous, Theophylline,Constant T,ConstantT,Ct, Theo Von,Glycinate, Theophylline Sodium,Quibron T SR,Quibron TSR,Slo Phyllin,SloPhyllin,Sodium Glycinate, Theophylline,Somophyllin T,SomophyllinT,Theo 24,Theo Dur,Theo24,Theophyllinate, Glycine,Von Ct, Theo

Related Publications

M J Otero, and A Martin, and M Barrueco, and M J Garcia, and A Dominguez-Gil
October 1991, Masui. The Japanese journal of anesthesiology,
M J Otero, and A Martin, and M Barrueco, and M J Garcia, and A Dominguez-Gil
November 1980, The Journal of allergy and clinical immunology,
M J Otero, and A Martin, and M Barrueco, and M J Garcia, and A Dominguez-Gil
January 1985, Annals of allergy,
M J Otero, and A Martin, and M Barrueco, and M J Garcia, and A Dominguez-Gil
January 1984, British journal of clinical pharmacology,
M J Otero, and A Martin, and M Barrueco, and M J Garcia, and A Dominguez-Gil
April 2023, Journal of Korean medical science,
M J Otero, and A Martin, and M Barrueco, and M J Garcia, and A Dominguez-Gil
December 1991, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
M J Otero, and A Martin, and M Barrueco, and M J Garcia, and A Dominguez-Gil
July 1989, The Journal of allergy and clinical immunology,
M J Otero, and A Martin, and M Barrueco, and M J Garcia, and A Dominguez-Gil
December 1982, Journal of adolescent health care : official publication of the Society for Adolescent Medicine,
M J Otero, and A Martin, and M Barrueco, and M J Garcia, and A Dominguez-Gil
May 1985, Annals of allergy,
M J Otero, and A Martin, and M Barrueco, and M J Garcia, and A Dominguez-Gil
July 1985, Annals of allergy,
Copied contents to your clipboard!